Log in to save to my catalogue

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulat...

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1315617884

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

About this item

Full title

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

Publisher

London: Nature Publishing Group UK

Journal title

Molecular psychiatry, 2013-03, Vol.18 (3), p.273-287

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Polymorphic drug-metabolizing enzymes (DMEs) are responsible for the metabolism of the majority of psychotropic drugs. By explaining a large portion of variability in individual drug metabolism, pharmacogenetics offers a diagnostic tool in the burgeoning era of personalized medicine. This review updates existing evidence on the influence of pharmac...

Alternative Titles

Full title

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1315617884

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1315617884

Other Identifiers

ISSN

1359-4184

E-ISSN

1476-5578

DOI

10.1038/mp.2012.42

How to access this item